Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $57 at Baird
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $13.19 -3.51%
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Baird analyst Brian Skorney lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $57.00 (from $60.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Truist Securities Upgrades First Financial Bancorp (FFBC) to Buy
- Meta Platforms Inc. (META) PT Raised to $995 at Tigress Financial Partners
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
